Serum uric acid levels during leprosy reaction episodes

Area of Science:

• * Immunology
• * Dermatology
• * Biochemistry

Background:

• * Leprosy reactions, particularly type 2 (erythema nodosum leprosum), are inflammatory episodes linked to oxidative stress.
• * Uric acid (UA) is recognized for its antioxidant properties in pathological conditions.
• * Understanding UA's role in leprosy reactions could offer insights into disease management.

Purpose of the Study:

• * To evaluate serum uric acid (UA) levels in leprosy patients with and without reactions.
• * To compare UA levels before and after treatment for leprosy reactions.
• * To investigate the potential role of UA in managing leprosy-associated oxidative stress.

Main Methods:

• * A cohort of 123 leprosy patients (aged 18-69) in Brazil were assessed.
• * Exclusion criteria included pregnancy, immunosuppressant use, and co-existing diseases like HIV or tuberculosis.
• * Serum UA levels were measured at baseline and at approximately 30 and 60 days post-treatment initiation.

Main Results:

• * Patients with type 2 leprosy reactions exhibited significantly lower serum UA levels compared to controls.
• * Reduced UA levels persisted in type 2 patients during follow-up assessments post-treatment.
• * Serum UA levels remained lower even after initiating anti-reaction therapies.

Conclusions:

• * Decreased serum UA in type 2 leprosy reactions may result from its consumption to combat increased reactive oxygen and nitrogen species.
• * Sustained low UA levels post-treatment suggest persistent oxidative stress.
• * Serum UA may function as an antioxidant during type 2 leprosy reactions.